PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Domperidone - Gastroparesis

PAD Profile : Domperidone - Gastroparesis Important

Brand Names Include :
Motilium
Important Information :
Refer to MHRA cardiac safety alerts. Off label use.

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Oral suspension
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Un
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
13 February 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Area Prescribing Committee recommends the use of domperidone for the treatment of gastroparesis in adults only when prescribed within a secondary care setting.

Domperidone will be considered RED on the traffic light system for this indication.

Prescribers should ensure that the patient understands the risks and consents to using domperidone off-label noting the MHRA alert (updated 2019) - https://www.gov.uk/drug-safety-update/domperidone-risks-of-cardiac-side-effects 

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication

Associated BNF Codes

04. Central Nervous System
04.06.00. Drugs used in nausea and vertigo
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More